These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 22841602)

  • 1. Assessment of the clinical significance of antigenic and functional levels of α1-proteinase inhibitor (α1-Pi) in infiltrating ductal breast carcinomas.
    Anes AB; Nasr HB; Hammann P; Kuhn L; Trimeche M; Hamrita B; Bougmiza I; Chaieb A; Khairi H; Chahed K
    Clin Biochem; 2012 Nov; 45(16-17):1421-31. PubMed ID: 22841602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomics-based identification of alpha1-antitrypsin and haptoglobin precursors as novel serum markers in infiltrating ductal breast carcinomas.
    Hamrita B; Chahed K; Trimeche M; Guillier CL; Hammann P; Chaïeb A; Korbi S; Chouchane L
    Clin Chim Acta; 2009 Jun; 404(2):111-8. PubMed ID: 19306859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha 1-antitrypsin: a novel tumor-associated antigen identified in patients with early-stage breast cancer.
    López-Árias E; Aguilar-Lemarroy A; Felipe Jave-Suárez L; Morgan-Villela G; Mariscal-Ramírez I; Martínez-Velázquez M; Alvarez AH; Gutiérrez-Ortega A; Hernández-Gutiérrez R
    Electrophoresis; 2012 Jul; 33(14):2130-7. PubMed ID: 22821488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterization of alpha1-proteinase inhibitor from common carp (Cyprinus carpio) seminal plasma.
    Wojtczak M; Całka J; Glogowski J; Ciereszko A
    Comp Biochem Physiol B Biochem Mol Biol; 2007 Nov; 148(3):264-76. PubMed ID: 17681818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of aberrant promoter methylation of GSTP1, RASSF1A, and RARβ2 in serum DNA of patients with breast cancer by a newly established one-step methylation-specific PCR assay.
    Yamamoto N; Nakayama T; Kajita M; Miyake T; Iwamoto T; Kim SJ; Sakai A; Ishihara H; Tamaki Y; Noguchi S
    Breast Cancer Res Treat; 2012 Feb; 132(1):165-73. PubMed ID: 21594664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A unique proteolytic fragment of alpha1-antitrypsin is elevated in ductal fluid of breast cancer patient.
    Zhou J; Trock B; Tsangaris TN; Friedman NB; Shapiro D; Brotzman M; Chan-Li Y; Chan DW; Li J
    Breast Cancer Res Treat; 2010 Aug; 123(1):73-86. PubMed ID: 19902353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
    D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
    Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the concentration of alpha 1-proteinase inhibitor reflect the transformation of liver cirrhosis to liver carcinoma?
    Dabrowska M; Mantur M; Panasiuk A; Prokopowicz J
    Neoplasma; 1997; 44(5):305-7. PubMed ID: 9473790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-1 antitrypsin (alpha1-AT) plasma levels in lung, prostate and breast cancer patients.
    El-Akawi ZJ; Al-Hindawi FK; Bashir NA
    Neuro Endocrinol Lett; 2008 Aug; 29(4):482-4. PubMed ID: 18766166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [alpha 1-proteinase inhibitor in breast cancer].
    Demidov VP; Iakubovskaia RI; Karmakova TA; Avdeev GI; Komissarov AB; Sorokin EE; Kotova TS
    Vopr Onkol; 1990; 36(1):23-9. PubMed ID: 2106187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Midkine in plasma as a novel breast cancer marker.
    Ibusuki M; Fujimori H; Yamamoto Y; Ota K; Ueda M; Shinriki S; Taketomi M; Sakuma S; Shinohara M; Iwase H; Ando Y
    Cancer Sci; 2009 Sep; 100(9):1735-9. PubMed ID: 19538527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent evidence of circulating tumor cells detected by means of RT-PCR for CEA mRNA predicts early relapse: a prospective study in node-negative breast cancer.
    Jotsuka T; Okumura Y; Nakano S; Nitta H; Sato T; Miyachi M; Suzumura K; Yamashita J
    Surgery; 2004 Apr; 135(4):419-26. PubMed ID: 15041966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of alpha-1 antitrypsin (alpha1-AT) and neopterin serum levels in the evaluation of non-small cell lung and prostate cancer patients.
    El-Akawi ZJ; Abu-Awad AM; Sharara AM; Khader Y
    Neuro Endocrinol Lett; 2010; 31(1):113-6. PubMed ID: 20150872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential protein expression in primary breast cancer and matched axillary node metastasis.
    Thongwatchara P; Promwikorn W; Srisomsap C; Chokchaichamnankit D; Boonyaphiphat P; Thongsuksai P
    Oncol Rep; 2011 Jul; 26(1):185-91. PubMed ID: 21503584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori infection and short-term intake of low-dose aspirin have different effects on alpha-1 antitrypsin/alpha-1 peptidase inhibitor (alpha1-PI) levels in antral mucosa and peripheral blood.
    Wex T; Kuester D; Vieth M; Treiber G; Krieg A; Roessner A; Malfertheiner P
    Scand J Gastroenterol; 2008; 43(10):1194-201. PubMed ID: 18609127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Change of HER-2/neu status in a subset of distant metastases from breast carcinomas.
    Regitnig P; Schippinger W; Lindbauer M; Samonigg H; Lax SF
    J Pathol; 2004 Aug; 203(4):918-26. PubMed ID: 15258994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of tumor antigens that elicit a humoral immune response in breast cancer patients' sera by serological proteome analysis (SERPA).
    Hamrita B; Chahed K; Kabbage M; Guillier CL; Trimeche M; Chaïeb A; Chouchane L
    Clin Chim Acta; 2008 Jul; 393(2):95-102. PubMed ID: 18424265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of chemotherapy on circulating angiogenic factor levels in patients with breast cancer].
    Tang JH; Zhao JH; Gong JP; Qin JW; Pan LQ; Xu ZY
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):210-4. PubMed ID: 17649639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Proliferation index and its prognostic value in invasive ductal breast carcinoma].
    Falco M
    Ann Acad Med Stetin; 2009; 55(1):22-30. PubMed ID: 20349588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of potential prognostic biomarkers for node-negative breast tumours by proteomic analysis: a multicentric 2004 national PHRC study.
    Descotes F; Jézéquel P; Spyratos F; Campion L; Grenot C; Lerebours F; Campone M; Guérin-Charbonnel C; Lanoë D; Adams M; André J; Carlioz A; Martin PM; Chassevent A; Jourdan ML; Guette C; Zanella-Cleon I; Ricolleau G
    Int J Oncol; 2012 Jul; 41(1):92-104. PubMed ID: 22552268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.